Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CDKN2A, CGAS, STING1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| p16^INK4a-CCF Axis as Senolytic Timing Biomarker | 0.725 | molecular biology | What is the optimal therapeutic window t |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| UNC93B1 promotes pancreatic cancer progression through modulation of cGAS-STING [PMID:41716413] | Yang H, Li Y, Su J, Zhang H, Zhu W et al | Front Immunol | 2026 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning CDKN2A, CGAS, STING1 in their description or question text
No additional research found